Stockholders’ Equity |
12 Months Ended | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Stockholders’ Equity [Abstract] | |||||||||||||||||||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | Note 7 STOCKHOLDERS’ EQUITY
Authorized Capital
As of December 31, 2025, the Company’s authorized capital stock consisted of:
Of the authorized preferred stock, 7,477,017 shares have been designated as Series A Convertible Preferred Stock.
Common Stock
As of December 31, 2025, and the subsequent period thereafter, there were 12,575,983 shares of common stock issued and outstanding. Series A Convertible Preferred Stock
In connection with the Merger (see Note 4), on December 1, 2025, the Company issued 7,477,017 shares of Series A Convertible Preferred Stock to the former stockholders of MindWave Innovations. The aggregate fair value of the Series A Preferred Stock was equivalent to the fair value of the net assets acquired from MindWave. The material terms of the Series A Preferred Stock are as follows:
The Company evaluated the Series A Preferred Stock under ASC 480 and determined that the instrument is classified in permanent equity based on the terms of the Merger. The issuance of 7,477,017 shares of Series A Preferred Stock at an aggregate fair value of $145,335,708 represents a non-cash financing activity and is disclosed in the supplemental schedule of non-cash activities. |
||||||||||||||||||||||||||||||||||||